Invited Speakers

Professor Georgina Long

Co-Medical Director of Melanoma Institute Australia

GLong_Headshot SmallProfessor Georgina Long, BSc PhD MBBS FRACP, is Co-Medical Director of Melanoma Institute Australia (MIA), and Chair of Melanoma Medical Oncology and Translational Research at MIA and Royal North Shore Hospital, The University of Sydney. She leads an extensive clinical trials team and laboratory at MIA, with a focus on targeted therapies and immuno-oncology in melanoma. She is principal investigator on phase I, II and III clinical trials in adjuvant and metastatic melanoma, including trials in patients with active brain metastases. She is the chief investigator on NHMRC funded research into the molecular biology of melanoma, with a particular interest in clinical and tissue biomarker correlates of systemic therapy sensitivity and resistance. In recognition of her ground breaking research, Professor Long has received a number of awards, including the prestigious Sir Zelman Cowen Universities Fund Prize for Discovery in Medical Research in 2016, and a number of recent CINSW Premiers Awards for Outstanding Cancer Research. In 2014, she was awarded the Wildfire Award for the most highly-cited, original, peer-reviewed article published in 2011; and in 2013 she was named the Outstanding Cancer Research Fellow. She is the author of over 160 peer-reviewed publications in clinical and translational research in melanoma since 2011, including the New England Journal of Medicine, Lancet, Lancet Oncology, Journal of Clinical Oncology and Cancer Discovery. Professor Long has presented her work at international conferences and meetings on more than 120 occasions. She is President-elect for the prestigious international Society for Melanoma Research (President from 2018), is member (2015-2017) and Chair (2016) of the ASCO Scientific Committee for Melanoma/Skin cancer, is medical oncology lead for the Australian Melanoma Management Guidelines Committee, is on the editorial boards of several high-impact journals, and is a member of the Melanoma Expert Panel for AJCC Cancer Staging System 8th edition.

Professor Long was awarded the University Medal in Organic Chemistry. She subsequently completed her PhD in Chemistry in the field of anti-cancer agents and their binding to DNA. She then moved to the USA to take up a Fulbright Postdoctoral Fellowship at Scripps Research Institute, exploring nanotechnology in cancer treatment, before returning to Australia to complete her MBBS (Hons). Professor Long became a Fellow of the Australasian College of Physicians in January 2008, specialising in medical oncology.

Professor Richard Scolyer

Co-Medical Director of Melanoma Institute Australia

28083FCE-E610-4661-AD9F7CE7CCFA70CC_mediumProfessor Richard Scolyer is Co-Medical Director of Melanoma Institute Australia; He is also Senior Staff Specialist, Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney; and Clinical Professor, The University of Sydney. Professor Scolyer studied medicine at the University of Tasmania. After completing clinical training in Australia and overseas, he undertook pathology training at the Canberra Hospital and at the Royal Prince Alfred Hospital leading to Fellowship of the Royal College of Pathologists of Australasia. Professor Scolyer has presented on more than 250 occasions at conferences throughout the world, and is a co-author of more than 500 articles and book chapters on melanocytic pathology and related research including publications in New England Journal of Medicine, Lancet, Nature, Nature Genetics, Lancet Oncology, Journal of Clinical Oncology and Cancer Discovery. In 2006, Professor Scolyer was awarded the degree of Doctor of Medicine by The University of Sydney for his thesis of publications on melanocytic pathology. He received a NSW Premier’s Award for Outstanding Cancer Research in 2009 and 2012, and the Thomson Reuters 2015 Citation Award in the Clinical Medicine category. In 2016, Professor Scolyer was appointed editor of the 4th Edition of the World Health Organisation Classification of Tumours Skin Tumours volume. He is also Vice Chair of the Melanoma Expert Panel of the American Joint Committee on Cancer (AJCC) for the 8th edition of the AJCC Cancer Staging System, Co-lead of the Australian Melanoma Genome Project, an editorial board member of the American Journal of Surgical Pathology, Melanoma Research and Melanoma Management, a member of the International Editorial Advisory Board of Histopathology and Senior Associate Editor of Pathology. Professor Scolyer is Immediate Past President of the Australasian Division of the International Academy of Pathology. Together with other MIA colleagues, Professor Scolyer is chief investigator on a 5-year NHMRC program grant and has a personal Fellowship from the NHMRC.

Registrations are Open!

Register Today!

WCCS 2018 Congress

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)